Literature DB >> 27147085

Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats.

Zhongli Yang1,2, Tanseli Nesil3, Kaitlyn P Connaghan2, Ming D Li1,3, Sulie L Chang4,5.   

Abstract

The human immunodeficiency virus-1 transgenic (HIV-1Tg) rat is a non-infectious rodent model for HIV-1 infection which develops altered immune-responses similar to those in persons infected with HIV-1. HIV-1Tg and F344 rats respond significantly different to morphine, ethanol, nicotine and other psychostimulants, although the molecular mechanisms underlying these differences remain largely undetermined. Here, we compared expression of 52 immune-related genes in the prefrontal cortex (PFC), nucleus accumbens (NAc), and ventral tegmental area (VTA) of HIV-1Tg and F344 rats treated with either nicotine (0.4 mg/kg nicotine, base, s.c.) or saline for 27 days, to identify differentially expressed genes in the presence of HIV-1 with and without nicotine treatment. Using quantitative RT-PCR array, we measured RNA expression levels. Results showed that RNA expression of CASP3, CCL5, CX3CL1, CX3CR1, IL1α, LRF4, LFR7, TGFβ1 and TLR4 in NAc, CCL2, CCL5, TGFβ1 and TLR4 in PFC, and CASP3, CX3CR1, IFNα1, IL1β and IL6 in VTA was significantly modulated in HIV-1Tg rats compared with F344 rats. IL1α showed a 58 % (P = 0.000072) decrease and IRF6 showed a 93.7 % increase (P = 0.000227) in the NAc of HIV-1Tg compared with F344 rats; results remained significant after correction for multiple testing. We also found that several genes were significantly modulated by nicotine in HIV-1Tg rats while only a small number of immune-related genes were altered by nicotine in F344 rats. These findings imply that HIV-1 viral proteins greatly impact immune function and alter responsiveness to nicotine in certain immune-related genes.

Entities:  

Keywords:  CNS immunity; HIV-1 transgenic rat; Nicotine; Nucleus accumbens; Prefrontal cortex; Ventral tegmental area

Mesh:

Substances:

Year:  2016        PMID: 27147085      PMCID: PMC4985440          DOI: 10.1007/s11481-016-9679-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  40 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.

Authors:  Claudia Cicala; James Arthos; Sara M Selig; Glynn Dennis; Douglas A Hosack; Donald Van Ryk; Marion L Spangler; Tavis D Steenbeke; Prateeti Khazanie; Neil Gupta; Jun Yang; Marybeth Daucher; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

3.  Identification and characterization of poly(I:C)-induced molecular responses attenuated by nicotine in mouse macrophages.

Authors:  Wen-Yan Cui; Shufang Zhao; Renata Polanowska-Grabowska; Ju Wang; Jinxue Wei; Bhagirathi Dash; Sulie L Chang; Jeffrey J Saucerman; Jun Gu; Ming D Li
Journal:  Mol Pharmacol       Date:  2012-10-01       Impact factor: 4.436

4.  Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells.

Authors:  Wen-Yan Cui; Ju Wang; Jinxue Wei; Junran Cao; Sulie L Chang; Jun Gu; Ming D Li
Journal:  Amino Acids       Date:  2011-12-21       Impact factor: 3.520

5.  Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.

Authors:  Riju Ray; Nandita Mitra; Don Baldwin; Mengye Guo; Freda Patterson; Daniel F Heitjan; Christopher Jepson; E Paul Wileyto; Jinxue Wei; Thomas Payne; Jennie Z Ma; Ming D Li; Caryn Lerman
Journal:  Neuropsychopharmacology       Date:  2010-02-10       Impact factor: 7.853

6.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.

Authors:  W Reid; M Sadowska; F Denaro; S Rao; J Foulke; N Hayes; O Jones; D Doodnauth; H Davis; A Sill; P O'Driscoll; D Huso; T Fouts; G Lewis; M Hill; R Kamin-Lewis; C Wei; P Ray; R C Gallo; M Reitz; J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 7.  Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC).

Authors:  P Portegies
Journal:  Drugs       Date:  1995       Impact factor: 9.546

8.  Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat.

Authors:  Natasha F Homji; Xin Mao; Erik F Langsdorf; Sulie L Chang
Journal:  J Neuroinflammation       Date:  2012-01-04       Impact factor: 8.322

9.  Nicotine attenuates the effect of HIV-1 proteins on the neural circuits of working and contextual memories.

Authors:  Tanseli Nesil; Junran Cao; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  Mol Brain       Date:  2015-07-24       Impact factor: 4.041

10.  Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat.

Authors:  Ming D Li; Junran Cao; Shaolin Wang; Ju Wang; Sraboni Sarkar; Michael Vigorito; Jennie Z Ma; Sulie L Chang
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

View more
  11 in total

Review 1.  Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.

Authors:  Haijun Han; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-13       Impact factor: 4.147

2.  Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.

Authors:  Ming D Li; Yih-Ing Hser; Zhiwei Chen; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-02       Impact factor: 4.147

3.  Age-Related Decrease in Tyrosine Hydroxylase Immunoreactivity in the Substantia Nigra and Region-Specific Changes in Microglia Morphology in HIV-1 Tg Rats.

Authors:  David R Goulding; Andrew Kraft; Peter R Mouton; Christopher A McPherson; Valeria Avdoshina; Italo Mocchetti; G Jean Harry
Journal:  Neurotox Res       Date:  2019-07-08       Impact factor: 3.911

Review 4.  Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.

Authors:  Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-13       Impact factor: 4.147

5.  Cigarette smoke and nicotine effects on brain proinflammatory responses and behavioral and motor function in HIV-1 transgenic rats.

Authors:  Walter Royal; Adem Can; Todd D Gould; Ming Guo; Jared Huse; Myles Jackson; Harry Davis; Joseph Bryant
Journal:  J Neurovirol       Date:  2018-04-11       Impact factor: 2.643

Review 6.  The Intersection of Sex Differences, Tobacco Use, and Inflammation: Implications for Psychiatric Disorders.

Authors:  Rebecca L Ashare; Reagan R Wetherill
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

7.  HIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats.

Authors:  Zhongli Yang; Tanseli Nesil; Taylor Wingo; Sulie L Chang; Ming D Li
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

Review 8.  Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders.

Authors:  Elena Irollo; Jared Luchetta; Chunta Ho; Bradley Nash; Olimpia Meucci
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

9.  MR brain volumetric measurements are predictive of neurobehavioral impairment in the HIV-1 transgenic rat.

Authors:  Rafael Casas; Siva Muthusamy; Paul G Wakim; Sanhita Sinharay; Margaret R Lentz; William C Reid; Dima A Hammoud
Journal:  Neuroimage Clin       Date:  2017-11-21       Impact factor: 4.881

10.  Binge-Like Exposure to Ethanol Enhances Morphine's Anti-nociception in B6 Mice.

Authors:  Sulie L Chang; Wenfei Huang; Haijun Han; Ilker K Sariyer
Journal:  Front Psychiatry       Date:  2019-01-22       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.